Cibc World Market Inc. Cuts Stake in The Clorox Company $CLX

Cibc World Market Inc. lessened its stake in The Clorox Company (NYSE:CLX) by 84.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,664 shares of the company’s stock after selling 14,605 shares during the quarter. Cibc World Market Inc.’s holdings in Clorox were worth $328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of CLX. Nomura Asset Management Co. Ltd. increased its holdings in Clorox by 9.0% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after acquiring an additional 27,639 shares in the last quarter. Hudson Bay Capital Management LP purchased a new stake in Clorox during the 2nd quarter valued at approximately $8,568,000. Vise Technologies Inc. bought a new stake in shares of Clorox during the second quarter valued at approximately $328,000. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Clorox by 64.2% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock worth $3,173,000 after buying an additional 10,065 shares in the last quarter. Finally, ProShare Advisors LLC boosted its position in shares of Clorox by 11.7% during the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after acquiring an additional 136,135 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.9%

Shares of NYSE CLX opened at $122.04 on Friday. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $159.04. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The business’s 50 day moving average is $109.36 and its two-hundred day moving average is $113.68. The stock has a market capitalization of $14.76 billion, a P/E ratio of 19.94, a PEG ratio of 0.61 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm posted $1.55 EPS. Clorox’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox published a consumer research report, “Home Care Redefined,” highlighting shifting demand toward wellness‑focused and convenience‑oriented home care — a narrative that supports Clorox’s premium, innovation and marketing strategies and could help sustain pricing/brand strength. Home Care Redefined
• Neutral Sentiment: Management presented prepared remarks at the Consumer Analyst Group of New York (CAGNY) conference; these presentations typically reiterate strategy and portfolio priorities but rarely change near‑term financials unless new guidance is provided. Investors will be watching for Q&A takeaways on cost savings, innovation cadence and margin recovery. CAGNY Prepared Remarks Transcript
• Neutral Sentiment: Wells Fargo reiterated a Hold on CLX (coverage note flagged in recent press), which is unlikely to trigger strong buying momentum; it keeps analyst sentiment around the stock cautious. Wells Fargo Hold
• Negative Sentiment: Zacks Research cut multiple near‑term EPS estimates (several quarters and FY2027 modestly lowered) and kept a “Hold” rating. The downward revisions signal weaker near‑term profit expectations and are the most direct driver of selling pressure today. (Source: Zacks research notes summarized across recent releases.)

Analysts Set New Price Targets

A number of brokerages have issued reports on CLX. Jefferies Financial Group reduced their price target on shares of Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Citigroup lifted their target price on Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Weiss Ratings downgraded Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, February 4th. Royal Bank Of Canada set a $132.00 price target on Clorox in a report on Wednesday, February 4th. Finally, Evercore reduced their price objective on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus target price of $118.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.